APA (7th ed.) Citation

Koletzko, S., Russell, R. K., Levine, A., Turner, D., Harris, R. E., Ridder, L. d., . . . Bigot, L. Protocol for a multinational risk-stratified randomised controlled trial in paediatric Crohn’s disease: Methotrexate versus azathioprine or adalimumab for maintaining remission in patients at low or high risk for aggressive disease course. BMJ Publishing Group.

Chicago Style (17th ed.) Citation

Koletzko, Sibylle, et al. Protocol for a Multinational Risk-stratified Randomised Controlled Trial in Paediatric Crohn’s Disease: Methotrexate Versus Azathioprine or Adalimumab for Maintaining Remission in Patients at Low or High Risk for Aggressive Disease Course. BMJ Publishing Group.

MLA (9th ed.) Citation

Koletzko, Sibylle, et al. Protocol for a Multinational Risk-stratified Randomised Controlled Trial in Paediatric Crohn’s Disease: Methotrexate Versus Azathioprine or Adalimumab for Maintaining Remission in Patients at Low or High Risk for Aggressive Disease Course. BMJ Publishing Group.